Variables (%) | Total | Survived the ICU | Died in the ICU | p value | |
---|---|---|---|---|---|
(n = 98) | (n =62) | (n =36) | |||
HAART | |||||
No past history of HAART | 24 (24.5) | 16 (25.8) | 8 (22.2) | 0.669 | |
No HAART at the admission + no introduction in ICU | 45 (45.9) | 28 (45.2) | 17 (47.2) | ||
No HAART at the admission + introduction in ICU | 9 (9.2) | 7 (11.3) | 2 (5.6) | 0.106 | |
HAART active at the admission and pursued | 20 (20.4) | 16 (25.8) | 4 (11.1) | ||
HAART active at the admission and stopped | 24 (24.5) | 11 (17.7) | 13 (36.1) | ||
Introducing or pursuing HAART in ICU | 29 (29.6) | 23 (37.1) | 6 (16.7) | 0.032 | |
Immunovirological data | |||||
Mean ± SD CD4 (/mm3) § | 173.5 ± 192 | 176.3 ± 197.1 | 168.7 ± 185.8 | 0.701¶ | |
Mean ± SD HIV RNA VL (103 copies/ml)¶ | 274. 8 ± 664.9 | 282.6 ± 709.5 | 261.1 ± 591 | 0.975 | |
CD4high (≥200/mm3) | 30 (32.3) | 20 (33.9) | 10 (29.4) | 0.656 | |
CD4low (<200/mm3) | 63 (67.7) | 39 (66.1) | 24 (70.6) | ||
Combined | CD4high + VLhigh | 14 (18.4) | 9 (18.4) | 5 (18.5) | |
subgroups | CD4high + VL low | 12 (15.8) | 10 (20.4) | 2 (7.4) | 0.429 |
CD4low + VLhigh | 40 (52.6) | 25 (51) | 15 (55.6) | ||
CD4low + VLlow | 10 (13.2) | 5 (10.2) | 5 (18.6) |